Albion VCTs closes oversubscribed £90M fundraise
Albion VCTs, the venture capital trusts known for backing high-growth UK companies such as Quantexa and Oviva, has closed an oversubscribed £90 million fundraise. The fresh capital will be deployed into UK-based deeptech, healthcare and B2B software scale-ups, underscoring strong investor confidence in the country’s innovation ecosystem despite broader market uncertainty.
Focus on deeptech, healthcare and B2B software
The new funding round will allow Albion VCTs to expand its portfolio of growth-stage businesses building defensible, technology-led solutions. Priority areas include AI-driven analytics, data infrastructure, digital health platforms, and mission-critical enterprise SaaS tools that serve regulated or complex industries.
By targeting scale-ups rather than very early-stage startups, the firm aims to back companies with proven product–market fit that are now ready to accelerate revenue, hiring and international expansion. Existing success stories such as Quantexa, a leader in data analytics and decision intelligence, and Oviva, a digital provider of healthcare and chronic condition management, illustrate the type of scalable business models the trusts seek to replicate.
Investor demand for resilient growth assets
The raise being oversubscribed reflects sustained demand from private investors for exposure to high-growth, tax-efficient UK venture capital opportunities. Venture capital trusts (VCTs) offer investors access to diversified portfolios of unlisted companies, with potential for long-term capital growth alongside government-backed tax incentives.
Market volatility and persistent concerns around inflation and interest rates have pushed many investors to look beyond public markets. Against this backdrop, vehicles like Albion VCTs are increasingly viewed as a way to participate in the upside of the UK’s innovation economy, particularly in sectors where regulation, strong intellectual property and recurring software revenue can help create durable competitive moats.
Implications for the UK innovation landscape
The £90 million raise adds further firepower to late-seed and Series A/B funding capacity within the UK, a stage often cited as a financing gap for domestic founders. By channeling capital into scalable deeptech, healthtech and B2B software ventures, Albion VCTs is positioned to support the next wave of nationally significant technology champions, while reinforcing the UK’s status as a leading hub for high-growth, knowledge-intensive businesses.